RICHARD H. SCHELLER - 11 May 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Dominic Piscitelli, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
11 May 2021
Net transactions value
-$12,623
Form type
4
Filing time
13 May 2021, 19:59:07 UTC
Next filing
18 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale $7,548 -300 -0.61% $25.16 49,200 11 May 2021 Direct F1, F2
transaction ORIC Common Stock Sale $2,575 -103 -0.21% $25.00 49,097 12 May 2021 Direct F1, F3
transaction ORIC Common Stock Sale $2,500 -100 -0.2% $25.00 48,997 13 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 300 shares sold in the price range of $25.09 to $25.27 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 103 shares sold in the price range of $25.00 to $25.13 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.